搜索临床试验以:Intermediate Risk Prostate Cancer
总计100201个结果
-
Abramson Cancer Center of the University of Pennsylvania完全的Lung Nodule, Breast, Kidney,Parathyroid, Mediastinal, Skin Mass, Soft Tissue, Prostate, Stomach Pleural, Head and Neck, and Are at Risk of Recurrence美国
-
The University of Texas Health Science Center at...完全的
-
M.D. Anderson Cancer CenterTeva Pharmaceuticals USA完全的
-
University of ChicagoNational Cancer Institute (NCI)完全的急性髓性白血病 | 继发性急性髓性白血病 | 骨髓增生异常综合症 | 继发性骨髓增生异常综合征 | 新生骨髓增生异常综合征美国
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的急性淋巴细胞白血病 | 成人 B 型急性淋巴细胞白血病 | 儿童 B 型急性淋巴细胞白血病美国, 加拿大, 澳大利亚, 新西兰, 瑞士
-
Astex Pharmaceuticals, Inc.完全的
-
Steba Biotech S.A.International Drug Development Institute; PrimeVigilance LTD终止
-
Blokhin's Russian Cancer Research Center邀请报名
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)撤销
-
Emory UniversityNational Cancer Institute (NCI)完全的
-
Spanish Oncology Genito-Urinary GroupPivotal S.L.主动,不招人前列腺癌 III 期 | 前列腺癌 IV 期
-
Baylor College of MedicineNational Cancer Institute (NCI)完全的
-
Sunnybrook Health Sciences CentreCanadian Association of Radiation Oncology完全的
-
East and North Hertfordshire NHS Trust未知
-
Sunnybrook Health Sciences Centre未知
-
University of Texas Southwestern Medical CenterAstellas Pharma US, Inc.完全的
-
Array Biopharma, now a wholly owned subsidiary...完全的
-
Array Biopharma, now a wholly owned subsidiary...完全的
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)撤销
-
University of OxfordMerck Sharp & Dohme LLC终止
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-Nürnberg完全的
-
Jonsson Comprehensive Cancer Center撤销复发性前列腺癌 | 第一阶段前列腺癌 | 前列腺癌 | IIA 期前列腺癌 | IIB 期前列腺癌
-
University of California, San Francisco完全的
-
Centre Hospitalier Universitaire de Nīmes完全的
-
University of AarhusOdense University Hospital; Rigshospitalet, Denmark; Herlev Hospital; Vejle Hospital; Aalborg University... 和其他合作者完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Novartis Pharmaceuticals终止